Mirae Asset Global Investments Co., Ltd. - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 48 filers reported holding PROQR THRAPEUTICS N V in Q4 2020. The put-call ratio across all filers is 13.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
Mirae Asset Global Investments Co., Ltd. ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q1 2022$286,000
-80.9%
315,080
+68.8%
0.00%
-100.0%
Q4 2021$1,495,000
+18.0%
186,663
+23.3%
0.00%0.0%
Q3 2021$1,267,000
+52.7%
151,402
+23.0%
0.00%
+50.0%
Q2 2021$830,000
+330.1%
123,083
+205.1%
0.00%
+100.0%
Q3 2020$193,000
+14.9%
40,342
+46.1%
0.00%0.0%
Q2 2020$168,000
+93.1%
27,612
+74.8%
0.00%0.0%
Q1 2020$87,000
-37.9%
15,798
+12.1%
0.00%0.0%
Q4 2019$140,00014,0870.00%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q4 2020
NameSharesValueWeighting ↓
M28 Capital Management LP 1,910,600$2,483,7802.85%
Privium Fund Management B.V. 5,344,446$6,947,7802.07%
DAFNA Capital Management LLC 940,582$1,222,7570.38%
Monaco Asset Management SAM 377,517$490,7720.15%
EcoR1 Capital, LLC 2,980,016$3,874,0210.13%
Ikarian Capital, LLC 472,625$614,4120.07%
FRANKLIN STREET ADVISORS INC /NC 150,000$1950.02%
ADAGE CAPITAL PARTNERS GP, L.L.C. 3,625,467$4,713,1070.01%
GSA CAPITAL PARTNERS LLP 74,084$960.01%
UBS OCONNOR LLC 189,328$246,1260.01%
View complete list of PROQR THRAPEUTICS N V shareholders